As gene-targeted therapies and ligand-modulating strategies advance, the clinical translation of TNFRSF12A may enable precision interventions that address inflammatory, proliferative, and degenerative states across central nervous system disorders. The gene discussed is TNFRSF12A; the disease is central nervous system disorder.